Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Optitable Technology is a Shanghai-based biotechnology company that provides an integrated AI and high-performance computing (HPC) platform for drug discovery. The company's core offering, the Opti-Life platform, leverages physics-based simulations and molecular dynamics to accelerate the identification and optimization of small molecule drug candidates. By optimizing the underlying storage and computational architecture, Optitable enables researchers to process massive datasets from cryo-electron microscopy and genomic sequencing more efficiently. The company focuses on tackling complex biological targets in therapeutic areas such as oncology and immunology. Optitable's approach combines deep expertise in computer science with structural biology to reduce the time and cost of early-stage drug development. Their solutions are utilized by both academic institutions and pharmaceutical companies to streamline the R&D pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Optitable Technology.